Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 2 |
2015 | 2 |
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Treatment preference for opioid use disorder among people who are incarcerated.
J Subst Abuse Treat. 2022 Jun;137:108690. doi: 10.1016/j.jsat.2021.108690. Epub 2021 Dec 13.
J Subst Abuse Treat. 2022.
PMID: 34930575
Free PMC article.
Anticipated Barriers to Sustained Engagement in Treatment With Medications for Opioid Use Disorder After Release From Incarceration.
Kaplowitz E, Truong A, Macmadu A, Berk J, Martin H, Burke C, Rich JD, Brinkley-Rubinstein L.
Kaplowitz E, et al.
J Addict Med. 2023 Jan-Feb 01;17(1):54-59. doi: 10.1097/ADM.0000000000001029. Epub 2022 Aug 2.
J Addict Med. 2023.
PMID: 35916404
Free PMC article.
Item in Clipboard
The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.
Laudenbach M, Tucker AM, Runyon SP, Carroll FI, Pravetoni M.
Laudenbach M, et al.
Vaccine. 2015 Nov 17;33(46):6332-9. doi: 10.1016/j.vaccine.2015.09.015. Epub 2015 Sep 26.
Vaccine. 2015.
PMID: 26409811
Free PMC article.
Item in Clipboard
The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse.
Laudenbach M, Baruffaldi F, Vervacke JS, Distefano MD, Titcombe PJ, Mueller DL, Tubo NJ, Griffith TS, Pravetoni M.
Laudenbach M, et al.
J Immunol. 2015 Jun 15;194(12):5926-36. doi: 10.4049/jimmunol.1500385. Epub 2015 May 13.
J Immunol. 2015.
PMID: 25972483
Free PMC article.
Item in Clipboard
Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.
Taylor JJ, Laudenbach M, Tucker AM, Jenkins MK, Pravetoni M.
Taylor JJ, et al.
J Immunol Methods. 2014 Mar;405:74-86. doi: 10.1016/j.jim.2014.01.010. Epub 2014 Jan 23.
J Immunol Methods. 2014.
PMID: 24462800
Free PMC article.
Item in Clipboard
Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.
Pravetoni M, Vervacke JS, Distefano MD, Tucker AM, Laudenbach M, Pentel PR.
Pravetoni M, et al.
PLoS One. 2014 May 5;9(5):e96547. doi: 10.1371/journal.pone.0096547. eCollection 2014.
PLoS One. 2014.
PMID: 24797666
Free PMC article.
Item in Clipboard
Cite
Cite